Secrecy in drug regulation

Abstract
The objective of this paper is to describe secrecy in drug regulation in Finland, by recording and reporting our experience in obtaining Norplant® licensing documentation. The materials used are the documents, phone calls and other contacts recorded

This publication has 0 references indexed in Scilit: